 TORONTO--BUSINESS WIRE--Titan Medical Inc. Titan or the Company TSX: TMD Nasdaq: TMDI, a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that on December 24, 2020, the Company received written notification from The Nasdaq Stock Market LLC Nasdaq that the Company has cured the bid price deficiency and has regained full compliance with all applicable criteria for continued listing and trading on The 